← Back to your selection

New Enterprise Associates (NEA)

Activity from announced rounds

Activity in this selectionUnited Kingdom · Oct 12, 2026 · Jan 1, 2026

New Enterprise Associates invests in technology and healthcare companies from incubation and seed through growth, with expertise spanning software, digital health and life sciences.

NEA operates dedicated early-stage and venture growth funds within its broader company-building strategy. Its healthcare mandate includes scientific development as well as digital products, while technology investing covers enterprise and consumer businesses.

This structure lets it engage with a team forming a company or with an established business financing expansion. The appropriate partner depends on both the development stage and whether the central challenge is technical, clinical or commercial.

Sources
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$700M
3 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1

By primary sector

AI2
Defense tech1

By country

United Kingdom3

Rounds

3 in this selection
CuspAI

Developing AI systems to discover and design new materials for clean energy and chipmaking

$450MSeries B
Role not disclosed
Valarian

Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems

$50MSeries A
Role not disclosed
Synthesia

Develops AI-powered digital avatars for corporate clients

$200MSeries E
Role not disclosed